Welcome to Dwaey, specifically on Drotaverine Hydrochloride page.
This medicine contains important and useful components, as it consists of
Drotaverine Hydrochloride is available in the market in concentration.
Drotaverine Hydrochloride
Drotaverine hydrochloride is an antispasmodic agent primarily used to relieve smooth muscle spasms in various parts of the body. It is generally considered safe but should be used with caution in patients with severe renal impairment, liver disease, or those who have a history of cardiovascular disease. Since Drotaverine is metabolized by the liver, individuals with hepatic dysfunction may require dose adjustments or close monitoring to avoid accumulation and toxicity.
Pregnant women should only use Drotaverine if the benefits outweigh the potential risks. It is categorized as a category C drug in pregnancy, meaning it should be used with caution and only if clearly needed. There is limited data on its use during lactation, and as such, it should be avoided during breastfeeding unless absolutely necessary.
Drotaverine is often used to treat spasm of smooth muscles, including those in the gastrointestinal tract, urinary tract, and bile ducts. Patients with a history of gastrointestinal ulcers or obstructions should be monitored closely, as Drotaverine may mask symptoms of underlying conditions. Additionally, this medication should be used cautiously in individuals who have hypotension or are taking antihypertensive medications, as Drotaverine may lower blood pressure in some cases.
Regular monitoring is advised for any changes in heart rate, blood pressure, or renal function during treatment, especially in high-risk patients.
Drotaverine hydrochloride is primarily used as an antispasmodic to alleviate smooth muscle spasms. It is effective in treating abdominal pain caused by gastrointestinal spasms and renal colic due to kidney stones. It is also commonly prescribed for dysmenorrhea (painful menstruation), which can result from uterine spasms. Furthermore, Drotaverine is indicated for the treatment of biliary colic, which is caused by spasms in the bile ducts.
This medication works by inhibiting phosphodiesterase 4 (PDE4), an enzyme responsible for smooth muscle contraction. In addition to these approved uses, Drotaverine may be employed off-label to manage muscle cramps and spasms related to other conditions, such as irritable bowel syndrome (IBS) or chronic pelvic pain, though these uses are more variable and should be evaluated on a case-by-case basis.
Drotaverine hydrochloride is contraindicated in patients with hypersensitivity to the drug or any of its components. Individuals with severe liver dysfunction or severe renal impairment should avoid this medication, as it may lead to the accumulation of the drug in the body, causing toxicity. Additionally, patients with gastrointestinal obstructions or ileus should not use Drotaverine, as the medication may mask symptoms of these conditions.
For individuals with low blood pressure (hypotension), Drotaverine should be used with caution, as it may further lower blood pressure in some cases, especially in combination with other antihypertensive medications. In pregnant women, the drug should only be used if clearly needed, and in breastfeeding women, it should be avoided unless the benefits outweigh the risks.
There are no specific age-related contraindications, but careful monitoring is advised for elderly patients, especially those with multiple comorbidities or who are taking multiple medications.
The side effects of Drotaverine hydrochloride are generally mild and well tolerated. Common side effects include:
- Nausea or vomiting: These symptoms are usually mild and resolve on their own.
- Dizziness or lightheadedness: Especially if standing up quickly, due to the potential blood pressure-lowering effect.
- Headache: Some users may experience a headache during treatment.
- Dry mouth: Less common but can occur.
- Constipation: As Drotaverine acts on the smooth muscles, it may occasionally result in mild constipation.
Less common but more serious side effects include:
- Severe allergic reactions (rash, itching, swelling, difficulty breathing).
- Hypotension: Especially when used in combination with other blood pressure-lowering medications.
- Tachycardia or palpitations: Although rare, these cardiovascular symptoms can occur if the drug causes significant changes in vascular tone.
If any of these symptoms occur or worsen, patients should seek medical attention promptly. Monitoring for signs of dehydration, low blood pressure, and electrolyte imbalances is advised during treatment, especially in elderly patients or those with underlying cardiovascular conditions.
3
Drotaverine hydrochloride works primarily by inhibiting phosphodiesterase 4 (PDE4), an enzyme that breaks down cyclic AMP (cAMP) in smooth muscle cells. By inhibiting this enzyme, Drotaverine increases cAMP levels, leading to the relaxation of smooth muscle fibers. This process reduces muscle spasms, particularly in the gastrointestinal, urinary, and biliary tracts, providing relief from painful cramping.
Drotaverine also has anticholinergic effects at higher concentrations, which can contribute to its ability to relieve spasms in various smooth muscle tissues. By decreasing the frequency and severity of spasms, Drotaverine helps reduce pain and discomfort in conditions like renal colic, gastrointestinal disorders, and menstrual cramps.
The drug is generally well absorbed and is rapidly metabolized by the liver. It has a short half-life, so it may need to be taken multiple times throughout the day for sustained effect.
Drotaverine hydrochloride has a relatively low interaction potential, but certain drug combinations can influence its effects. Concomitant use with other antihypertensive drugs (such as ACE inhibitors, beta-blockers, or calcium channel blockers) may enhance the blood pressure-lowering effects of Drotaverine, leading to an increased risk of hypotension. As a result, patients using these medications should have their blood pressure monitored regularly.
Drotaverine should not be used in combination with other antispasmodics unless prescribed by a healthcare provider, as combining these medications may increase the risk of unwanted side effects like excessive relaxation of smooth muscles, potentially leading to gastrointestinal or urinary retention.
No significant interactions with common antibiotics, antifungals, or antidepressants are typically noted; however, as always, it is important to inform healthcare providers about all current medications to avoid any unforeseen drug interactions.
For most adult patients, the typical starting dose of Drotaverine hydrochloride is 40 mg two to three times daily, depending on the severity of the condition. In cases of more severe spasms or pain, the dose may be increased, but the maximum recommended dose should not exceed 240 mg per day. The drug should be taken orally, and it is usually administered with food to minimize the likelihood of gastrointestinal side effects.
The dose may be adjusted based on individual patient response, and it is important to follow the prescribing doctor’s recommendations. If the patient experiences dizziness, headache, or gastrointestinal issues, the dosage may need to be reduced or adjusted. Patients who are at risk for hypotension should be monitored more closely when starting Drotaverine therapy.
Drotaverine hydrochloride is not typically recommended for use in children under the age of 18, as its safety and efficacy in pediatric populations have not been established. The use of this medication in younger patients should be considered on a case-by-case basis, with a healthcare provider evaluating the potential risks and benefits.
In cases where Drotaverine is considered for pediatric use, the dose should be adjusted based on age and weight, but it should generally be lower than the adult dose. Careful monitoring of any potential side effects, particularly those involving the gastrointestinal and cardiovascular systems, is essential in younger patients.
For patients with renal impairment, Drotaverine hydrochloride should be used with caution. No specific dosage adjustments are typically required for mild to moderate renal impairment, but the drug should be avoided in patients with severe renal dysfunction (e.g., creatinine clearance <30 mL/min), as Drotaverine can accumulate in the body and cause increased side effects.
In patients with renal disease, careful monitoring of renal function and electrolytes, particularly potassium levels, is advised during treatment.
Not available in a medicine form yet